Today on Pharmaceutical Processing
Why continuously monitoring COVID-19 vaccines’ temperature is critical
Freudenberg Sealing Technologies touts new high-performance seals for butterfly valves
Regulatory See More >
Trump’s latest drug pricing plan will likely face legal challenges
President Trump recently unveiled his latest initiative to standardize drug pricing, tying government drug payments to lower prices abroad. Trump also signaled his intent to eliminate pharmaceutical industry middlemen — pharmacy-benefit managers — who are “ripping off Medicare patients with high prescription prices,” he said. The policies, the president claimed, are the “the biggest ever…
Facility See More >
Digital shift management cures pharma processing communication woes
The increasing complexity of drugs — including vaccines, biologics, sterile injectables and cell therapies — brings pharmaceutical companies significant manufacturing challenges during the pandemic. In turn, this complexity drives supply chain disruptions and changes to business and operational processes to accommodate social distancing, remote working and quarantining. Some pharmaceutical manufacturers have prioritized the manufacture of…
Supply Chain See More >
Why continuously monitoring COVID-19 vaccines’ temperature is critical
While vaccine hesitancy will be a barrier in battling the COVID-19 pandemic, the storage requirements for SARS-CoV-2 vaccines will invariably be another significant hurdle. The BNT162b2 vaccine candidate from Pfizer (NYSE:PFE) — with its subarctic storage requirements of -70°C — could be especially vexing. Approximately 5% of the vaccine, which Pfizer developed with partner BioNTech (NSDQ:BNTX), could…
Recalls See More >
GSK, Pfizer and J&J among the most-fined drug companies, according to study
GlaxoSmithKline (LON:GSK) paid nearly $10 billion in inflation-adjusted financial penalties between January 2003 and December 2016, the highest tally for any drug company, according to research published in JAMA. That sum was more than any other in a sampling of 26 companies paying fines inside the U.S. Pfizer (NYSE: PFE) was next in line with…
Nostrum Laboratories recalls Type 2 diabetes drug over contamination problems
Flu vaccination worries rise in South Korea following deaths
Torrent Pharmaceuticals Issues Voluntary Nationwide Recall of Losartan Potassium Tablets
